Back to Search Start Over

Adjunctive gentamicin did not improve outcome of enterococcal bacteraemia in neutropenic patients: a propensity scored matched study.

Authors :
Jent, Philipp
Thalmann, Laura
Pabst, Thomas
Droz, Sara
Sendi, Parham
Source :
Infectious Diseases. Jun2019, Vol. 51 Issue 6, p409-416. 8p. 1 Diagram, 3 Charts, 2 Graphs.
Publication Year :
2019

Abstract

Background: Patients with haematologic malignancies receiving chemotherapy have a high risk of developing febrile neutropenia and bloodstream infections. The benefit of adjunctive gentamicin treatment for enterococcal bloodstream infections is debated. In this study, we compare the treatment outcome of a cell wall-active antibiotic with and without gentamicin for enterococcal bacteraemia in patients with neutropenia. Methods: The observational study was performed from 1999 through 2016. Patients with bacteraemia due to non-high level gentamicin-resistant enterococci were included. Analyses were performed in two data sets of episodes with enterococcal bacteraemia. One data set consisting of all included episodes (full cohort, n = 154) and one with propensity score-matched episodes (n = 96). The primary endpoint was death within 30 days, and the secondary outcomes were defervescence and persistence of enterococcal bloodstream infection after initiation of anti-enterococcal therapy. Results: Episodes with gentamicin treatment (n = 82, full cohort; n = 48, propensity score-matched cohort) were comparable with episodes without gentamicin treatment (n = 72, full cohort; n = 48, propensity score-matched cohort) with regard to patient- and disease-related characteristics. Enterococcus faecium (40.9%) was the most frequently isolated organism. In the propensity score-matched cohort, there was no difference in 30-days mortality (14.6% in episodes with gentamicin versus 16.7% in episodes without gentamicin, p = 1), median time to defervescence (1 versus 2 days, p =.37) or persistence of enterococcal bloodstream infection for ≥72 h (9.4% versus 7.5%, p = 1). Conclusions: In our study with neutropenic patients, treatment with a cell wall-active antibiotic without adjunctive gentamicin for episodes with enterococcal bloodstream infection was as effective as combination therapy with gentamicin. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
23744235
Volume :
51
Issue :
6
Database :
Academic Search Index
Journal :
Infectious Diseases
Publication Type :
Academic Journal
Accession number :
136379952
Full Text :
https://doi.org/10.1080/23744235.2019.1581946